Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 7 of 7 entries
View as:

A Phase I, the Study to Evaluate the Safety, Immunogenicity and Efficacy of YS-HBV-002

Phase: N/A Priority: Normal
NCT ID: NCT06162299 Org: User:
Start: 07/01/24 End: 10/31/24 Due: 10/31/25

A Phase I Study to Evaluate Safety, Tolerability, and Immunogenicity of a PIKA COVID-19 Vaccine in Healthy Individuals

Phase: N/A Priority: Normal
NCT ID: NCT05305300 Org: User:
Start: 10/18/21 End: 09/15/22 Due: 09/15/23

Dose Escalation and Cohort Expansion Study of YS-ON-001 in Patients With Advanced Solid Tumors

Phase: N/A Priority: Normal
NCT ID: NCT03131765 Org: User:
Start: 04/20/17 End: 12/16/19 Due: 12/16/20

Efficacy and Safety of a PIKA Rabies Vaccine Containing the PIKA Adjuvant With an Accelerated Regimen

Phase: N/A Priority: Normal
NCT ID: NCT02956421 Org: User:
Start: 02/29/16 End: 10/31/16 Due: 10/31/17

A Phase II/III Study of PIKA Recombinant SARS-CoV-2 Vaccine as a Booster Dose.

Phase: N/A Priority: Normal
NCT ID: NCT05463419 Org: User:
Start: 10/03/22 End: 04/11/24 Due: 04/11/25

A Study to Evaluate a PIKA Rabies Vaccine（Vero Cell）for Human Use,Freeze-dried

Phase: N/A Priority: Normal
NCT ID: NCT05667974 Org: User:
Start: 09/22/23 End: 02/21/25 Due: 02/21/26

Safety and Efficacy of a PIKA Rabies Vaccine Containing the PIKA Adjuvant

Phase: N/A Priority: Normal
NCT ID: NCT02657161 Org: User:
Start: 02/28/15 End: 07/31/15 Due: 07/31/16